KR100871499B1 - 불임치료용 ｆｓｈ의 용도 - Google Patents

불임치료용 ｆｓｈ의 용도 Download PDF

Info

Publication number
KR100871499B1
KR100871499B1 KR1020077017998A KR20077017998A KR100871499B1 KR 100871499 B1 KR100871499 B1 KR 100871499B1 KR 1020077017998 A KR1020077017998 A KR 1020077017998A KR 20077017998 A KR20077017998 A KR 20077017998A KR 100871499 B1 KR100871499 B1 KR 100871499B1
Authority
KR
South Korea
Prior art keywords
dose
fsh
days
pharmaceutical composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077017998A
Other languages
English (en)
Korean (ko)
Other versions
KR20070087253A (ko
Inventor
어네스트 로우메이에
메이어스 루이스 듀에르-
Original Assignee
라보라토리스 세로노 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100871499(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/en
Application filed by 라보라토리스 세로노 에스.에이. filed Critical 라보라토리스 세로노 에스.에이.
Publication of KR20070087253A publication Critical patent/KR20070087253A/ko
Application granted granted Critical
Publication of KR100871499B1 publication Critical patent/KR100871499B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020077017998A 2000-01-27 2001-01-09 불임치료용 ｆｓｈ의 용도 Expired - Lifetime KR100871499B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00300591.5 2000-01-27
EP00302840.4 2000-04-04
EP00302840A EP1142582A1 (en) 2000-04-04 2000-04-04 Use of FSH for treating infertility

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020027009518A Division KR100871502B1 (ko) 2000-01-27 2001-01-09 불임치료용 ｆｓｈ의 용도

Publications (2)

Publication Number Publication Date
KR20070087253A KR20070087253A (ko) 2007-08-27
KR100871499B1 true KR100871499B1 (ko) 2008-12-05

Family

ID=26072975

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020077017998A Expired - Lifetime KR100871499B1 (ko) 2000-01-27 2001-01-09 불임치료용 ｆｓｈ의 용도
KR1020027009518A Expired - Lifetime KR100871502B1 (ko) 2000-01-27 2001-01-09 불임치료용 ｆｓｈ의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020027009518A Expired - Lifetime KR100871502B1 (ko) 2000-01-27 2001-01-09 불임치료용 ｆｓｈ의 용도

Country Status (29)

Country Link
US (1) US7291593B2 (https=)
EP (2) EP1442748A1 (https=)
JP (1) JP5170928B2 (https=)
KR (2) KR100871499B1 (https=)
CN (1) CN1418107A (https=)
AR (1) AR027287A1 (https=)
AT (1) ATE267608T1 (https=)
AU (1) AU783121B2 (https=)
BG (1) BG65915B1 (https=)
BR (1) BR0107881A (https=)
CA (1) CA2397680A1 (https=)
CZ (1) CZ302835B6 (https=)
DE (1) DE60103503T3 (https=)
DK (1) DK1250148T4 (https=)
EA (1) EA004924B1 (https=)
EE (1) EE05444B1 (https=)
ES (1) ES2217113T5 (https=)
HR (1) HRP20020630A2 (https=)
HU (1) HU230833B1 (https=)
IL (2) IL150837A0 (https=)
MX (1) MXPA02007233A (https=)
NO (1) NO324626B1 (https=)
PL (1) PL211113B1 (https=)
PT (1) PT1250148E (https=)
RS (1) RS50805B (https=)
SI (1) SI1250148T2 (https=)
SK (1) SK287717B6 (https=)
TR (1) TR200401810T4 (https=)
WO (1) WO2001054715A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS21004A (sr) * 2001-09-12 2006-12-15 Aplied Research Systems Ars Holding N.V. Upotreba hcg u kontrolisanoj hiperstimulaciji ovarijuma
MXPA04002257A (es) 2001-09-12 2004-07-23 Applied Research Systems Uso de gonadotropina corionica humana (gch) y su hormona de liberacion (hl) en hiperestimulacion ovarica controlada.
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
WO2008140794A1 (en) * 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
AR081755A1 (es) * 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
WO2015089656A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
MX2020002235A (es) * 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
NO324626B1 (no) 2007-11-26
DK1250148T3 (da) 2004-08-16
SK10962002A3 (sk) 2002-12-03
EE200200415A (et) 2003-12-15
EP1442748A1 (en) 2004-08-04
EA004924B1 (ru) 2004-10-28
EP1250148B1 (en) 2004-05-26
IL150837A (en) 2010-12-30
JP5170928B2 (ja) 2013-03-27
BG106943A (bg) 2003-02-28
US20030158106A1 (en) 2003-08-21
CZ20022555A3 (cs) 2002-11-13
BG65915B1 (bg) 2010-05-31
AR027287A1 (es) 2003-03-19
WO2001054715A1 (en) 2001-08-02
MXPA02007233A (es) 2003-02-12
US7291593B2 (en) 2007-11-06
KR20020081273A (ko) 2002-10-26
BR0107881A (pt) 2003-04-01
EE05444B1 (et) 2011-08-15
YU56702A (sh) 2005-09-19
HUP0204324A2 (en) 2003-05-28
NO20023354L (no) 2002-09-24
KR20070087253A (ko) 2007-08-27
EA200200801A1 (ru) 2003-02-27
ES2217113T5 (es) 2008-11-01
IL150837A0 (en) 2003-02-12
DE60103503T2 (de) 2005-06-09
DE60103503D1 (de) 2004-07-01
KR100871502B1 (ko) 2008-12-05
SI1250148T1 (en) 2004-08-31
SI1250148T2 (sl) 2008-10-31
PL356925A1 (en) 2004-07-12
ES2217113T3 (es) 2004-11-01
PL211113B1 (pl) 2012-04-30
CZ302835B6 (cs) 2011-11-30
HRP20020630A2 (en) 2004-12-31
HU230833B1 (hu) 2018-07-30
CN1418107A (zh) 2003-05-14
SK287717B6 (en) 2011-07-06
NO20023354D0 (no) 2002-07-11
TR200401810T4 (tr) 2004-09-21
DK1250148T4 (da) 2008-09-22
AU2532101A (en) 2001-08-07
CA2397680A1 (en) 2001-08-02
RS50805B (sr) 2010-08-31
DE60103503T3 (de) 2008-12-24
HUP0204324A3 (en) 2004-12-28
PT1250148E (pt) 2004-09-30
ATE267608T1 (de) 2004-06-15
EP1250148A1 (en) 2002-10-23
AU783121B2 (en) 2005-09-29
JP2003520823A (ja) 2003-07-08
EP1250148B2 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
RS56702B1 (sr) Anti-fap antitela i metode primene
KR100871499B1 (ko) 불임치료용 ｆｓｈ의 용도
AU2003274929B2 (en) Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
JP2003520823A5 (https=)
CN115803046A (zh) 用于治疗不育症的包含hp-hmg的组合物
AU2005203211B2 (en) Use of FSH for treating infertility
EP1142582A1 (en) Use of FSH for treating infertility
EA049091B1 (ru) КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ HP-hMG, ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ БЕСПЛОДИЯ
HK1053426A (en) Use of fsh for treating infertility
EP3932419A1 (en) Methods of treating infertility

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20070803

Application number text: 1020027009518

Filing date: 20020724

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070828

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20071112

Patent event code: PE09021S01D

N234 Change of applicant [patent]: notification of change of applicant and registration of full transfer of right
PN2301 Change of applicant

Patent event date: 20080118

Comment text: Notification of Change of Applicant and Registration of Full Transfer of Right

Patent event code: PN23012R02D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080513

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20080911

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20081125

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20081125

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20111102

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20111102

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20121102

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20121102

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20131101

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20131101

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20141104

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20141104

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20151102

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20151102

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20161028

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20171030

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20171030

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20181119

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20181119

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20191118

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20191118

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20201119

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20201119

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term